1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America PACS and RIS Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America PACS and RIS Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America PACS and RIS Market Regional Analysis
6.2 North America PACS and RIS Market Revenue 2017-2027 (US$ Million)
6.3 North America PACS and RIS Market Forecast Analysis
7. North America PACS and RIS Market Analysis – by Product
7.1 PACS
- 7.1.1 Overview
- 7.1.2 PACS: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 RIS
- 7.2.1 Overview
- 7.2.2 RIS: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America PACS and RIS Market Analysis – by Component
8.1 Hardware
- 8.1.1 Overview
- 8.1.2 Hardware: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Software
- 8.2.1 Overview
- 8.2.2 Software: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Services
- 8.3.1 Overview
- 8.3.2 Services: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America PACS and RIS Market Analysis – by Deployment
9.1 Web-Based
- 9.1.1 Overview
- 9.1.2 Web-Based: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 On-Premise and Cloud-Based
- 9.2.1 Overview
- 9.2.2 On-Premise and Cloud-Based: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America PACS and RIS Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.2 Diagnostic Centers
- 10.2.1 Overview
- 10.2.2 Diagnostic Centers: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.3 Research & Academic Institutes
- 10.3.1 Overview
- 10.3.2 Research & Academic Institutes: North America PACS and RIS Market – Revenue and Forecast, 2017-2027 (US$ Million)
11. North America PACS and RIS Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America PACS and RIS Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 11.2.1.1 North America PACS and RIS Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.1.1 US: North America PACS and RIS Market Breakdown, by Product
- 11.2.1.1.2 US: North America PACS and RIS Market Breakdown, by Component
- 11.2.1.1.3 US: North America PACS and RIS Market Breakdown, by Deployment
- 11.2.1.1.4 US: North America PACS and RIS Market Breakdown, by End User
- 11.2.1.2 Canada:
North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.2.1 Canada: North America PACS and RIS Market Breakdown, by Product
- 11.2.1.2.2 Canada: North America PACS and RIS Market Breakdown, by Component
- 11.2.1.2.3 Canada: North America PACS and RIS Market Breakdown, by Deployment
- 11.2.1.2.4 Canada: North America PACS and RIS Market Breakdown, by End User
- 11.2.1.3 Mexico :
North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.3.1 Mexico : North America PACS and RIS Market Breakdown, by Product
- 11.2.1.3.2 Mexico : North America PACS and RIS Market Breakdown, by Component
- 11.2.1.3.3 Mexico : North America PACS and RIS Market Breakdown, by Deployment
- 11.2.1.3.4 Mexico : North America PACS and RIS Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Agfa-Gevaert Group
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 INFINITT Healthcare Co., Ltd.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 McKesson Corporation
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cerner Corporation
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 General Electric Company
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Koninklijke Philips N.V.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 FUJIFILM Holdings Corporation
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Siemens AG
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 IBM
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Novarad
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations